Two types are pathogenic in AML: FLT3-ITD (Internal Tandem Duplication) and FLT3-TKD (Tyrosine kinase Domain) mutations, for which the prevalence is respectively 20–25% and 7–9% in adult patients. The gene discussed is FLT3; the disease is acute myeloid leukemia.